Cumberland Pharmaceuticals

NASDAQ: CPIX

$4.12USD

+0.06 (+1.48%)At close: Apr 27, 14:04 UTC

Open

$4.12

Prev. Close

$4.12

High

$4.12

Low

$4.12

Key Stats

Market Cap

$60.72M

Dividend Yield

–

P/E Ratio

-21.4

EPS

-0.47

Revenue

$37.87M

Avg. Volume

10.9M

TL;DR

emptyResult

Recently from Cashu

Cumberland Pharmaceuticals Enters $100 Million Deal with Apotex to Enhance Growth and Pipeline

Cumberland Pharmaceuticals Inc. announces a major strategic agreement with Apotex, paving the way for a substantial integration of their branded pharmaceutical businesses in the U.S. The deal, valued…

Cashu Markets·9h ago

Cumberland Pharmaceuticals' Caldolor Approved for Expanded Use in Postoperative Pain Management

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) has received FDA approval for an expanded indication for its flagship ibuprofen product, Caldolor®. This approval allows Caldolor to be utilized for mana…

Cashu Markets·7 days ago

Cumberland Pharmaceuticals Launches New Sancuso® Website for Enhanced CINV Management Resources

Cumberland Pharmaceuticals Enhances CINV Management Through New Sancuso® Website Cumberland Pharmaceuticals Inc., a Nashville-based specialty pharmaceutical company, has recently launched a revamped w…

Cashu Markets·1 month ago

Cumberland Pharmaceuticals Innovates Amidst Broader Economic Shifts and Anticipated Earnings Reports

Cumberland Pharmaceuticals Focuses on Healthcare Innovation Amid Anticipated Earnings Reports in Broader Economy As the healthcare sector continues to evolve, Cumberland Pharmaceuticals sees significa…

Cashu Markets·2 months ago